WHO Launches Global Strategic Preparedness and Response Plan to Curb Monkeypox Outbreak
- Moderna Latest Study: mRNA Therapy for Treating T Cell-Mediated Autoimmune Diseases
- The Biosecure Act May Hurt Pharmaceutical Supply Chains
- Mosquito Elimination on Global Health: Unraveling the Claim of 700K Annual Deaths
- Intensive Blood Pressure Management to Below 140 mmHg Reduces Stroke Risk, Regardless of Medication Dosage
- GLP-1 Drugs: How Significant is Their Impact on Brain Health?
- Why Eel Sashimi Is Unsafe: Understanding the Risks of Consuming Raw Eel
WHO Launches Global Strategic Preparedness and Response Plan to Curb Monkeypox Outbreak
- Shocking! All existing AIDS vaccine developments have failed
- Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
- CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
WHO Launches Global Strategic Preparedness and Response Plan to Curb Monkeypox Outbreak
On August 26, the World Health Organization (WHO) initiated a Global Strategic Preparedness and Response Plan aimed at halting the spread of monkeypox through coordinated global, regional, and national efforts. This follows the WHO’s previous declaration of the monkeypox outbreak as a “Public Health Emergency of International Concern.”
This plan, covering the six months from September 2024 to February 2025, requires an estimated $135 million in funding, which will be jointly raised by WHO, member states, and partners.
To meet the needs of implementing this plan, the WHO will soon launch a fundraising appeal to improve equitable access to vaccines, particularly in African countries most severely impacted by the outbreak.
The plan is based on interim and long-term recommendations issued by WHO Director-General Dr. Tedros Adhanom Ghebreyesus, with a focus on comprehensive monitoring, prevention, preparedness, and response strategies. It also aims to advance research and ensure fair access to medical countermeasures such as diagnostic tests and vaccines, minimize animal-to-human transmission, and enhance community engagement in outbreak prevention and control.
Dr. Tedros emphasized last week, “Let me be clear: this new monkeypox outbreak is controllable and preventable. Addressing this complex outbreak requires a comprehensive and coordinated international response.”
Strategic vaccination efforts will focus on those at highest risk, including close contacts of recent cases and healthcare workers, to interrupt transmission chains.
In essence, global efforts will center on ensuring strategic leadership, providing guidance based on the latest evidence, and ensuring that those at highest risk in affected countries have access to necessary medical interventions.
To this end, WHO headquarters and regional offices have established Incident Management Support Teams and have significantly increased staff deployment to affected countries.
Later this week, the WHO Research and Development Blueprint team will host an online scientific meeting with the Africa CDC, the Coalition for Epidemic Preparedness Innovations (CEPI), and the National Institute of Allergy and Infectious Diseases to align research and outbreak control goals for monkeypox.
Dr. Tedros reiterated on Monday that the monkeypox outbreak in Congo and neighboring countries is controllable and preventable. “Achieving this requires a comprehensive and coordinated action plan between international agencies, national and local partners, civil society, researchers, manufacturers, and our member states. The strategy is rooted in principles of equity, global solidarity, community empowerment, human rights, and cross-sectoral coordination.”
On Monday, the German government announced a donation of 100,000 doses of monkeypox vaccines to African countries affected by the outbreak. These vaccines come from the Bundeswehr’s stockpile. Additionally, Germany will establish a mobile laboratory in Congo for rapid monkeypox virus testing.
Last week, France committed to providing 100,000 doses of vaccines to African countries, and Austrian officials stated they would donate vaccines, though the exact number is not yet clear.
Meanwhile, the Philippine Department of Health reported two new confirmed cases of monkeypox in the capital region of Manila, with no clarity on whether these cases involve the 1b variant. Last week, Thailand confirmed its first case of the monkeypox 1b variant.
WHO Launches Global Strategic Preparedness and Response Plan to Curb Monkeypox Outbreak
______________________________
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
